Cel Sci (CVM) Capital Leases (2012 - 2026)
Cel Sci's Capital Leases was $3.78 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 39.7% from $6.27 million a year earlier and down 14.6% from the prior quarter.
Powered by 
Analysis
Cel Sci (CVM) Capital Leases (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Capital Leases at Cel Sci came in at $5.68 million, down 28.6% from FY2024.
- Capital Leases has now declined for four consecutive fiscal years, with a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
- In earlier fiscal years, Capital Leases was $7.96 million in FY2024 (-20.0%), $9.95 million in FY2023 (-15.1%), $11.72 million in FY2022 (-11.6%) and $13.25 million in FY2021 (+12.8%).
- The fiscal Q3 2026 figure marks the lowest quarterly Capital Leases since fiscal Q2 2013.
- Compared with a year earlier, Capital Leases has declined for 17 straight quarters, with an average decline of 28.3% over the last eight quarters.
- The best year-over-year quarter for Capital Leases over five years was fiscal Q4 2021 (growth of 12.8%); the worst was fiscal Q3 2026 (a decline of 39.7%).
- Per Business Quant data, CVM's Capital Leases in the three fiscal quarters before Q3 2026 was $4.43 million (Q2 2026), $5.07 million (Q1 2026) and $5.68 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Cel Sci | 3.11 Mn | -22.54 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.78 Mn |
| Mar 31, 2026 | 4.43 Mn |
| Dec 31, 2025 | 5.07 Mn |
| Sep 30, 2025 | 5.68 Mn |
| Jun 30, 2025 | 6.27 Mn |
| Mar 31, 2025 | 6.85 Mn |
| Dec 31, 2024 | 7.41 Mn |
| Sep 30, 2024 | 7.96 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 8.99 Mn |
| Dec 31, 2023 | 9.47 Mn |
| Sep 30, 2023 | 9.95 Mn |
| Jun 30, 2023 | 10.41 Mn |
| Mar 31, 2023 | 10.86 Mn |
| Dec 31, 2022 | 11.30 Mn |
| Sep 30, 2022 | 11.72 Mn |
| Jun 30, 2022 | 12.12 Mn |
| Mar 31, 2022 | 12.49 Mn |
| Dec 31, 2021 | 12.88 Mn |
| Sep 30, 2021 | 13.25 Mn |
API Access
Cel Sci Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=CVM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "CVM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=CVM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();